No Detail Found!

Determining the release kinetics of risperidone controlled release matrices to treat schizophrenia

Author(s)
Zeb-un-Nisa Faculty of Pharmacy, Ziauddin University,Karachi,Pakistan
Asia Naz Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi, Pakistan
Syed Imran Ali Faculty of Pharmacy, Ziauddin University,Karachi,Pakistan
Mehwish Rizvi College of Pharmacy, Dow University of Health Sciences,Karachi,Pakistan
Muhammad Shahid Iqbal College of Pharmacy, Prince Sattam bin Abdulaziz University,Al-Kharj,Saudi Arabia
Saira Shahnaz Nazeer Hussain University,Karachi,Pakistan
Ale Zehra College of Pharmacy, Dow University of Health Sciences,Karachi,Pakistan
Samina Sheikh Faculty of Pharmacy, Ziauddin University,Karachi,Pakistan
Shaheen Perveen Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University,Karachi,Pakistan
Hira Arif Faculty of Pharmacy, Ziauddin University,Karachi,Pakistan
Saba Inayat College of Pharmacy, Dow University of Health Sciences,Karachi,Pakistan
Muhammad Mustafa Swaleh Faculty of Pharmacy, Ziauddin University,Karachi,Pakistan
Sadia Suri Kashif Faculty of Pharmacy, Ziauddin University,Karachi,Pakistan
Mehwish Murad Ali Faculty of Pharmacy, Ziauddin University,Karachi,Pakistan
Hira Akhtar Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Karachi, Pakistan
Abstract
Risperidone is an atypical antipsychotic agent clinically used to treat schizophrenia, bipolar diseases, and autism. Usually, the frequency of doses is twice daily. In the present study, risperidone controlled release matrices formulated using hydrophilic and hydrophobic polymers. The tablets were prepared by direct compression. The precompression and post-compression properties were assessed, along with swelling studies. The morphology of particles observed using scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FT-IR). The stability study on the drug was performed using thermal gravimetric analysis (TGA) and differential thermal analysis (DTA). The optimized formulation was prepared with the help of hydrophilic polymer K100M (40% ratio). Furthermore, release kinetics had investigated. The release pattern of optimized formulation FT5 fitted best to zero-order kinetics and showed excellent release characteristics. The model-independent approach had been used, formulations FT6 and FT8 showed resemblance with FT5 in all three media, respectively. The once daily formulation of risperidone could be beneficial for schizophrenia patients and their caregivers and will improve patient compliance.
Publication Details
Page(s) 657-663
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP2, Year: 2021

Request the full text from PASTIC

Keywords
Matrix, TGA, zero-order kinetics, SEM, stability, hydrophilic
References
Agarwal P and Semimul A .2018 .A comprehensive review on sustained release matrix tablets: a promising dosage form. UJPR, 3(6) : 49-54.
Aulton ME,Taylor KM ME .2017 .Aulton's Pharmaceutics E-Book: The design and manufacture of medicines. Elsevier Health Sciences, : 566-575.
Arévalo R,Maderuelo C .2019 .Identification of the critical variables for the development of controlled release matrix tablets: Factorial design approach. , 4(1) : 250.
Pharmacopoeia British .2009 .British Pharmacopoeia Commission. The Stationery Office Limited, : 6578-6585.
Bourne D ,Banker GS .2002 .Pharmacokinetics. Marcel Dekker, : 66-91.
Cao QR,Choi YW,Cui JH,Lee BJ .2005 .Effect of solvents on physical properties and release characteristics of monolithic hydroxypropylmethylcellulose matrix granules and tablets. Arch. Pharm. Res., 28(4) : 493-501.
Lobo Costa P,JMS Costa P .2001 .Modeling and comparison of dissolution profiles. Eur. J Pharm. Sci., 13(2) : 123-133.
Coughlin JM,Wang Y,Ambinder EB,Ward RE,Minn I,Vranesic M,Pomper MG M .2016 .In vivo markers of inflammatory response in recent-onset schizophrenia: A combined study using [11 C] DPA713 PET and analysis of CSF and plasma. Transl. Psychiatry, 6(4) : e777-e777.
Davoodi P,Lee LY,Xu Q,Sunil V,Sun Y,Soh S,Wang CH .2018 .Drug delivery systems for programmed and on-demand release. Adv. Drug Deliv. Rev., 132(10) : 104-138.
Dedania ZR,Dedania RR,Sheth NR,Patel JB,Patel B .2011 .Stability indicating HPLC determination of risperidone in bulk drug and pharmaceutical formulations. Int. J. Anal. Chem, : .
El-Masry SM,Helmy SA .2020 .Hydrogel-based matrices for controlled drug delivery of etamsylate: Prediction of in-vivo plasma profiles. Saudi Pharm. J., 28(12) : 1704-1718.
FDA U .1997 .Guidance for Industry: Dissolution testing of immediate-release solid oral dosage forms. Food and Drug Administration, Center for Drug Evaluation and Research (CDER. , : 1-11.
Ghori MU,Ginting G,Smith AM,Conway BR .2014 .Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices. Int. J. Pharm., 465(1-2) : 405-412.
Grant S and Fitton A .1994 .. Risperidone. Drugs, 48(2) : 253-273.
Hixson AW,Crowell JH .1931 .Dependence of reaction velocity upon surface and agitation. Ind. Eng. Chem, 23(8) : 923-931.
ICH .2003 .Q1A (R2)-Stability testing of new drug substances and products. International Conference on Harmonisation (ICH), : 1-24.
ICH I .2005 .Q2 (R1): Validation of analytical procedures: Text and methodology. , : .
Joshi SC .2011 .Sol-gel behavior of hydroxypropyl methylcellulose (HPMC) in ionic media including drug release. Mater., 4(10) : 1861-1905.
Kamboj S,Gupta GD,Oberoy J .2017 .Matrix tablets: An important tool for oral controlled release dosage form. Pharmainfo. Net., 7(6) : 1-9.
Katzung BG .2017 .Basic and clinical pharmacology 14th edition. McGraw Hill Professional, : 504-519.
Klancar U,Baumgartner S,Legen I,Smrdel P,Kampus NJ,Krajcar D,Markun B,Kocevar K B .2015 .Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high-dose BCS class I model drug: in vitro and in vivo studies. AAPS. Pharm. Sci. Tech, 16(2) : 398-406.
Klancar U,Horvat M,Baumgartner S M .2012 .Correlating cellulose derivative intrinsic viscosity with mechanical susceptibility of swollen hydrophilic matrix tablets. AAPS. Pharm. Sci. Tech, 13(3) : 903-910.
Klancar U,Markun B,Baumgartner S,Legen I .2013 .A novel beads-based dissolution method for the in vitro evaluation of extended release HPMC matrix tablets and the correlation with the in vivo data. AAPS. J., 15(1) : 267-277.
Kohrs NJ,Liyanage T,Venkatesan N,Najarzadeh A,Puleo DA .2019 .Drug delivery systems and controlled release. Elsevier, : 316-329.
Korsmeyer RW,Gurny R,Doelker E,Buri P,Peppas NA .1983 .Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm., 15(1) : 25-35.
Kumar M,Sharma P,Maheshwari R,Tekade M,Shrivastava SK,Tekade RK .2018 .Beyond the blood-brain barrier: Facing new challenges and prospects of nanotechnology-mediated targeted delivery to the brain. In: Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors, : 397-437.
Leon JD,Susce MT,Pan RM,Wedlund PJ,Orrego ML,Diaz FJ .2007 .A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels. Pharmacopsychiatry, 40(3) : 93-102.
Mannens GEERT,Huang ML,Meuldermans WILLEM,Hendrickx J,Woestenborghs ROBERT,Heykants JOSEPH .1993 .Absorption, metabolism, and excretion of risperidone in humans. Drug. Metab, 21(6) : 1134-1141.
O'hara T,Dunne A,Butler J,Devane J .1998 .A review of methods used to compare dissolution profile data. Pharmaceut. Sci. Tech, 1(5) : 214-223.
Patrick JS,Martin A .2017 .Martin's physical pharmacy and pharmaceutical sciences. , : 492-510.
Raghuvanshi S and Pathak K .2014 .Recent advances in delivery systems and therapeutics of cinnarizine: A poorly water soluble drug with absorption window in stomach. J. Drug. Deliv., : 1-15.
Shah RB,Tawakkul MA,Khan MA .2008 .Comparative evaluation of flow for pharmaceutical powders and granules. Aaps. Pharm. Sci. Tech, 9(1) : 250-258.
Shah VP,Tsong Y,Sathe P,Liu JP .1998 .In vitro dissolution profile comparison statistics and analysis of the similarity factor, f2. Pharm. Res., 15(6) : 889-896.
Svarstad BL,Shireman TI,Sweeney JK .2001 .Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. , 52(6) : 805-811.
Sweetman S. . .The Complete Drug Reference (Extra Pharmacopoeia-Martindale). Cloth, 20 : 1024-1027.
Thombre AG,Wu XY .2019 .Controlled release technology and design of oral controlled release dosage forms. Chemical engineering in the pharmaceutical industry: Drug Product Design. , : 381-407.
Jain Ummaheshwari R,NK Ummaheshwari R .2018 .Controlled and novel drug delivery systems. CBS Publishers and Distributors, 408 : .
USP35-NF30 U (2012b). United States . .Pharmacopeial. , : .
Shmeis Wang Z,RA Wang Z .2006 .Dissolution controlled drug delivery systems. Design of controlled release drug delivery systems. United States: McGraw-Hill, : 139-172.
Weiden PJ,Mackell JA,McDonnell DD .2004 .Obesity as a risk factor for antipsychotic noncompliance. Schizophr. Res., 66(1) : 51-57.
0

Citations

0

Downloads

8

Views